Novartis Türkiye Health Innovation Program

Solutions that improve patient access to innovative medicines in out-of-pocket market and enabling innovative finance in healthcare.

Focus Areas

1. Smart Payments & Financial Access

Fast and accessible payment solutions using Open Banking, digital wallets, and cross-border payments.

2. Innovative Insurance & Outcome-Based Models

Insurtech solutions, and alternative funding models.

3. Secure & Integrated Financing Infrastructure

Crowdfunding, RTBC, and integrated financial workflows for healthcare providers.

Digital health solutions that increase awareness, enable earlier detection, and improve symptom management and treatment outcomes in cardiovascular diseases.

Focus Areas

1. Risk Awareness & Preventive Health

Solutions that increase awareness of cardiovascular risk factors, support preventive health approaches, and help identify high-risk populations at an early stage.

2. AI-Driven Early Detection & Screening

AI and data-driven technologies that enable earlier identification of cardiovascular risks and support more effective screening and diagnostic processes.

3. Digital Disease Management, Symptom Monitoring & Treatment Adherence

Solutions that support long-term cardiovascular disease management by improving treatment adherence, enabling continuous monitoring of patient health, and supporting the management of symptoms and overall patient outcomes.

Solutions that increase awareness, enable early diagnosis, improve treatment adherence, and strengthen recurrence risk awareness in early-stage breast cancer.

Focus Areas

1. Screening Awareness & Early Detection

Solutions that increase screening participation and regular mammography follow-up for women aged 40+.

2. AI-Powered Clinical Decision Support

AI-based tools that support physicians in imaging, diagnostics, and clinical decision-making in early-stage breast cancer.

3. Recurrence Risk Awareness & Risk Categorization

Solutions that increase awareness of recurrence risk among patients and healthcare professionals and support multidisciplinary alignment for accurate risk categorization.

4. Treatment Adherence & Long-Term Patient Support

Digital solutions that support treatment adherence, side-effect management, psychological support, and long-term patient follow-up throughout the patience journey.

Solutions that increase awareness of SMA screening premerital in Türkiye and strengthen informed decision-making through guidance, psychological support, and preventive health approaches for at-risk couples.

Focus Areas

1. SMA Awareness & Continuous Education

Digital and community-based solutions that improve awareness of SMA carrier status and provide continuous, easy-to-understand education for at-risk couples.

2. Enhance Guidance & Decision Support

Digital platforms offering personalized guidance, second opinions, and alternative pathways based on premarital screening results.

3. Psychological Support & Community Partnerships

Solutions that enable psychological support, patient communication, and local or cultural partnerships to encourage informed behavior change.

Digital health solutions that enable early diagnosis, shorten the Diagnose journey, and improve treatment adherence and quality of life in urticaria and related skin conditions.

Focus Areas

1. Early Diagnosis & Decision Support at First Point of Care

AI-powered tools that support fast and accurate diagnosis in primary care, emergency departments, and pharmacies.

2. Digital Screening, Monitoring & Patient Tracking

Solutions using image recognition, mobile applications, and wearables to monitor lesions, itching, and disease flares.

3. Treatment Adherence, Information Access & Quality of Life

Patient-centric digital solutions that improve adherence, provide reliable medical information, and reduce the psychosocial burden of the disease.

As the official representation of Switzerland, the Swiss Embassy covers all matters concerning diplomatic relations between the two countries. It represents Swiss interests in the areas of political, economic, financial and legal affairs, as well as science, education and culture.

Swissnex is the Swiss global network connecting Switzerland and the world in education, research and innovation.

Swissnex mission is to support its partners’ outreach and active engagement in the international exchange of knowledge, ideas and talent. Together with the six main locations established in the world’s most innovative regions and around 20 Science Offices and Counselors based in Swiss embassies, Swissnex contributes to strengthen Switzerland’s profile as a world-leading hotspot of innovation.

The core values of Swissnex are:

• Connecting its partners to thriving innovation ecosystems worldwide.
• Advising on trends and opportunities in science, education and innovation.
• Promoting the visibility of Swiss higher education and research institutions, startups and other innovation-driven partner organizations.

• Inspiring new ideas by promoting knowledge exchange.

MEXT is a digital, green, and AI transformation center founded in 2020 by the Turkish Employers’ Association of Metal Industries (MESS). Through its state-of-the-art facility, assessments, training programs, and ecosystem-driven approach, MEXT supports companies across industries in accelerating their digital and sustainable transformation journeys. 

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 300 million people worldwide. Reimagine medicine with Novartis Türkiye: www.novartis.com.tr, www.linkedin.com/company/novartisturkiye, www.instagram.com/novartisturkiye/.

• Startups operating in the health, life sciences, or digital health space
• A ready product or solution is required (applications based solely on an undeveloped concept will not be considered)
• Startups with an existing deployment or real-world use case are strongly encouraged to apply

• Solutions aligned with one or more of the defined Health Innovation Program challenge areas

• A clearly defined target user or customer segment (e.g. patients, healthcare professionals, providers, payers, or institutions)
• A clear and well-articulated problem statement and value proposition
• Ambition to scale and create measurable impact beyond a single use case

• Ability to participate in key program touchpoints and online sessions
• Mandatory participation in the Challenge Day on June 11th, 2026, in Ankara
• All Challenge Day pitches must be delivered in English

• Compliance with applicable legal and regulatory frameworks
• Commitment to ethical innovation, data protection, privacy, and transparency